Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-24-002989

President & CEO sold 30,000 shares at $45.00 ($1,350,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KAKKIS EMIL D President & CEO 2024-02-07 Sale −30,000 $45.00 $1,350,000 539,770 D: show line 1 in the form
Open-market sales · 30,000 sh · avg $45.00 · $1,350,000
Loading xslF345X05/doc4.xml…